rAAV6-microdystrophin preserves muscle function and extends lifespan in severely dystrophic mice.
- Published in:
- Nature Medicine, 2006, v. 12, n. 7, p. 787, doi. 10.1038/nm1439
- By:
- Publication type:
- Article
Works matching AU Blankinship, Michael J.
Results: 14
1
2
Systemic delivery of genes to striated muscles using adeno-associated viral vectors.
- Published in:
- Nature Medicine, 2004, v. 10, n. 8, p. 828, doi. 10.1038/nm1085
- By:
- Publication type:
- Article
3
Fluorophore-labeled myosin-specific antibodies simplify muscle-fiber phenotyping.
- Published in:
- Muscle & Nerve, 2008, v. 37, n. 1, p. 104, doi. 10.1002/mus.20877
- By:
- Publication type:
- Article
4
Evaluation of Vascular Delivery Methodologies to Enhance rAAV6-mediated Gene Transfer to Canine Striated Musculature.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 8, p. 1427, doi. 10.1038/mt.2009.116
- By:
- Publication type:
- Article
5
Erratum to “Efficient Transduction of Skeletal Muscle Using Vectors Based on Adeno-associated Virus Serotype 6”.
- Published in:
- 2009
- By:
- Publication type:
- Correction Notice
6
Systemic Microdystrophin Gene Delivery Improves Skeletal Muscle Structure and Function in Old Dystrophic mdx Mice.
- Published in:
- Molecular Therapy, 2008, v. 16, n. 4, p. 657, doi. 10.1038/mt.2008.28
- By:
- Publication type:
- Article
7
Systemic Administration of Micro-dystrophin Restores Cardiac Geometry and Prevents Dobutamine-induced Cardiac Pump Failure.
- Published in:
- Molecular Therapy, 2007, v. 15, n. 6, p. 1086, doi. 10.1038/sj.mt.6300144
- By:
- Publication type:
- Article
8
Design of Tissue-specific Regulatory Cassettes for High-level rAAV-mediated Expression in Skeletal and Cardiac Muscle.
- Published in:
- Molecular Therapy, 2007, v. 15, n. 2, p. 320, doi. 10.1038/sj.mt.6300027
- By:
- Publication type:
- Article
9
35. Systemic Administration of rAAV6-Microdystrophin Preserves Muscle Function and Extends Lifespan in the Dystrophin-/Utrophin- Mouse Model of Severe Muscular Dystrophy.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S15, doi. 10.1016/j.ymthe.2006.08.048
- By:
- Publication type:
- Article
10
561. Novel Tissue-Specific Regulatory Cassettes Direct High-Level Transgene Expression in Skeletal and Cardiac Muscle.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S216, doi. 10.1016/j.ymthe.2006.08.634
- By:
- Publication type:
- Article
11
Gene Therapy Strategies for Duchenne Muscular Dystrophy Utilizing Recombinant Adeno-associated Virus Vectors.
- Published in:
- Molecular Therapy, 2006, v. 13, n. 2, p. 241, doi. 10.1016/j.ymthe.2005.11.001
- By:
- Publication type:
- Article
12
791. Immunity to AAV-Mediated Gene Therapy in a Random-Bred Canine Model of Duchenne Muscular Dystrophy
- Published in:
- 2005
- By:
- Publication type:
- Abstract
13
266. Development of rAAV-Based Skeletal and Cardiac Muscle Regulatory Cassettes for Gene Therapy of Duchenne Muscular Dystrophy
- Published in:
- 2005
- By:
- Publication type:
- Abstract
14
Efficient transduction of skeletal muscle using vectors based on adeno-associated virus serotype 6
- Published in:
- Molecular Therapy, 2004, v. 10, n. 4, p. 671, doi. 10.1016/j.ymthe.2004.07.016
- By:
- Publication type:
- Article